Product Images Gabapentin

The text represents a graph or chart showing the results of a study that compares the effectiveness of Gabapentin and the placebo in managing pain over a period of 8 weeks, comprised of a 4-week Dose Titration Period and a 4-week Fixed Dose Period. The pain scores are shown on the vertical axis, with the baseline and consecutive weeks indicated on the horizontal axis. Gabapentin appears to be significantly more effective than the placebo, as indicated by the asterisk and the p-value.*

This is a graph that shows the mean pain score over a 3-week dose titration period and a 4-week fixed dose period for a placebo group, and groups taking Gabapentin at 1800 mg/day and 2400 mg/day. The graph indicates that the groups taking Gabapentin experienced significantly less pain compared to the placebo group. The significance of the results is denoted by "**p <0.01".*

This text presents data on the percentage of responders at endpoint for two different studies involving a drug called GBP compared to a placebo (PBO) with different dosages. The symbols "*k" and "***" denote statistical significance levels at p<0.01 and p<0.001, respectively. The exact nature of the endpoint is not clear from the available text.*

This text contains medication dosage instructions and some important information like lot number, expiration date, storage instructions, and contact details. It also mentions the name of the manufacturer and distributor. However, due to the presence of symbols, errors, and incomplete sentences, a useful description cannot be generated.*